ஷாங்காய் மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஷாங்காய் மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஷாங்காய் மருந்துகள் Today - Breaking & Trending Today

Global Tumor Necrosis Factor Inhibitors Drug Market Top Manufacturers, Latest Innovation with Trends

Global Tumor Necrosis Factor Inhibitors Drug Market Top Manufacturers, Latest Innovation with Trends
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , South Africa , Saudi Arabia , Guo Jian , Enbrel Etanercept , Simponi Golimumab , Aryogen Biopharma , Hanall Biopharma , Zydus Cadila , Otezla Apremilast , Cimzia Certolizumab Pegol , Samsung Bioepis , Remicade Infliximab , Mark Stone , Humira Adalimumab , Shanghai Pharmaceuticals , Celgene Corporation , Momenta Pharmaceuticals , Reliance Life Sciences , Intas Pharmaceuticals , Simcere Pharmaceutical , Lg Life Sciences , Head Of Business Development , Tumor Necrosis Factor Inhibitors Drug , Southeast Asia ,

Breast Cancer Monoclonal Antibodies Market to Witness Huge Growth | Major Giants Amgen, Roche, Mylan

Breast Cancer Monoclonal Antibodies Market to Witness Huge Growth | Major Giants Amgen, Roche, Mylan ....

United States , United Kingdom , New Zealand , South Korea , South Africa , United Arab Emirates , Saudi Arabia , Vladimir Putin , Asia Pacific , Linkedin Facebook Twittertags , Research Media , Research Scope The Breast Cancer Monoclonal Antibodies , Porters Five , Customization Service Of The , Peer Group Analysis , See Campaign , Research Newswire , Matrix Company Profile , Research Parameter Methodology Primary , Manufacturers Company , Shanghai Pharmaceuticals Holding , Global Breast Cancer Monoclonal Antibodies Market , Breast Cancer Monoclonal Antibodies Market , Cancer Monoclonal Antibodies Market , Breast Cancer Monoclonal Antibodies , Sample Report ,

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary

Share this article
Share this article
Continues to boost production capacity to meet increasing demand
Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions
95.47% effective overall in preventing severe COVID-19 diseases 14 days after vaccination
Vaccines provide timely mass protection for adults aged 18 and above, including those over 60
TIANJIN, China, March 22, 2021 /PRNewswire/ CanSinoBIO Biologics Inc. ( CanSinoBIO ) (HKEX: 06185) today announced that the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI) granted emergency use authorization for its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ( Ad5-nCoV , trade name: Convidecia™). The approval is based on the vaccine s interim results for Phase III clinical trial and marks the first approval of Convidecia™ in an European Union member state. ....

Shanghai Pharmaceuticals , Cansinobio Biologics Inc , Commission For Protection , Drug Regulatory Authority Of Pakistan , European Union , Hungarian National Institute Of Pharmacy , National Medical Products Administration Of China , Hungarian National Institute , Recombinant Novel Coronavirus Vaccine , Adenovirus Type , Chief Executive Officer , National Medical Products Administration , Federal Commission , Sanitary Risks , Drug Regulatory Authority , Executive Director , Chief Scientific Officer , ஷாங்காய் மருந்துகள் , தரகு க்கு ப்ரொடெக்ஶந் , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , ஐரோப்பிய தொழிற்சங்கம் , பசி தேசிய நிறுவனம் ஆஃப் மருந்தகம் , பசி தேசிய நிறுவனம் , தலைமை நிர்வாகி அதிகாரி , கூட்டாட்சியின் தரகு , சுகாதார அபாயங்கள் ,

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cansino Biologics Inc , Shanghai Pharmaceuticals , Drug Regulatory Authority Of Pakistan , Hungarian National Institute Of Pharmacy , Commission For Protection , Cansinobio Biologics Inc , European Union , National Medical Products Administration Of China , Hungarian National Institute , Recombinant Novel Coronavirus Vaccine , Adenovirus Type , Chief Executive Officer , National Medical Products Administration , Federal Commission , Sanitary Risks , Drug Regulatory Authority , Executive Director , Chief Scientific Officer , Sino Biologics , கேன்சினோ உயிரியல் இன்க் , ஷாங்காய் மருந்துகள் , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , பசி தேசிய நிறுவனம் ஆஃப் மருந்தகம் , தரகு க்கு ப்ரொடெக்ஶந் , ஐரோப்பிய தொழிற்சங்கம் , பசி தேசிய நிறுவனம் ,

Chinese online pharmacy SPH gathers $159.7m in Series B round

Chinese online pharmacy SPH gathers $159.7m in Series B round
Visual from Shanghai Pharmaceuticals website.
February 18, 2021
SPH Health Commerce, a Chinese Internet hospital and online pharmacy, has completed its Series B round of financing at 1.033 billion yuan ($159.7 million).
With this, the company will not be a controlled subsidiary of the country’s drug developer and distributor Shanghai Pharmaceuticals.
Shanghai-based SPH, which was founded in March 2015 by Shanghai Pharma, saw the stake held by the parent reduce to nearly 48% from 72.7% after the transaction, SPH announced in a statement on Thursday.
The billion-yuan investment was completed on January 18. As a result of the new financing, Hong Kong and Shanghai-listed Shanghai Pharma will no longer consolidate the financials of SPH into its financial statements. ....

Hong Kong , Shanghai Pharmaceuticals , Shanghai Charity Foundation , Shanghai Biomedical Industrial Equity Investment Fund , Valliance Capital , Sph Health Commerce , Shanghai International Group , Chinese Internet , Shanghai Pharma , Shanghai Listed Pharma , Shanghai City , China Jianyin , New Alliance Capital , Ample Harvest Finance , Xinte Pharmaceutical Chain , Cardinal China , Cardinal Health , Softbank China Venture Capital , ஹாங் காங் , ஷாங்காய் மருந்துகள் , ஷாங்காய் தொண்டு அடித்தளம் , ஷாங்காய் உயிர் மருத்துவ தொழில்துறை பங்கு முதலீடு நிதி , கூட்டணி மூலதனம் , ஷாங்காய் சர்வதேச குழு , சீன இணையதளம் , ஷாங்காய் பார்மா ,